Mesirow Institutional Investment Management, Inc. Catalyst Pharmaceuticals, Inc. Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.09 Billion
- Q2 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 934,234 shares of CPRX stock, worth $20.3 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
934,234
Previous 719,104
29.92%
Holding current value
$20.3 Million
Previous $11.5 Million
26.25%
% of portfolio
1.32%
Previous 1.07%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
299Shares Held
97.5MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$407 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$199 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$176 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$131 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$65.3 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.24B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...